FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a compound of structural formula (I) possessing inhibitory activity on the TAM family of receptor tyrosine kinases (RTKs). In formula (I) A represents C-R10; B represents C-R11, N; R1, R4 are independently specified in -H, -F, -Cl, -Br, -I, -OH, -NH2, -OCH3, -OC2H5, -OC3H7, -OCH(CH3)2, -NO2, -CHO, -COCH3, -COC2H5, -COC3H7, -O-cyclo-C3H5, -OCH2-cyclo-C3H5, -O-C2H4-cyclo-C3H5, -OCF3, -OC2F5, -CH2F, -CHF2, -CF3, -CH2Cl, -CH2Br, -CH2I, -CH2-CH2F, -CH2-CHF2, -CH2-CF3, -CH2-CH2Cl, -CH2-CH2Br, -CH2-CH2I, cyclo-C3H5, -CH2-cyclo-C3H5, -CH3, -C2H5, -C3H7, -CH(CH3)2, -C4H9, -CH2-CH(CH3)2, -CH(CH3)-C2H5, -C(CH3)3, -CH=CH2, -CH2-CH=CH2, -C(CH3)=CH2, -CH=CH-CH3; R2 are R3 are independently specified in -O-R18, -O-CR73R74-R18, -O-CR73R74-CR75R76-R18, -O-CR73R74-CR75R76-CR77R78-R18, -O-CR73R74-CR75R76-CR77R78-CR79R80-R18; R5 and R6 represent -H; R7, R8, which can be identical or different from each other, represent -H, -F, -Cl, -Br, -I, -CN, -NO2, -CH3, -C2H5, -C3H7, -CH(CH3)2, cyclo-C3H5, -CH2-cyclo-C3H5, -OCH3; R9 represents -H. The radical values D, R10, R11, R18, R73-R80 are presented in the patent claim. The invention also refers to a pharmaceutical composition containing the above compound.
EFFECT: producing the compounds possessing the inhibitory activity on the TAM family of receptor tyrosine kinases (RTKs).
14 cl, 3 tbl, 106 ex
Title | Year | Author | Number |
---|---|---|---|
PYRAZOLOTRIAZINE DERIVATIVES AS SELECTIVE INHIBITORS OF CYCLIN-DEPENDENT KINASES | 2013 |
|
RU2645347C2 |
PYRIDINONE DERIVATIVES AS TISSUE TRANSGLUTAMINASE INHIBITORS | 2013 |
|
RU2652987C2 |
1-(4-ISOXAZOLE-5-YL)-1H-PYRAZOLE-1-YL)-2-METHYLPROPANE-2-OL DERIVATIVES AND RELATED COMPOUNDS AS IL-17 AND IFN-GAMMA INHIBITORS FOR TREATMENT OF AUTOIMMUNE DISEASES AND CHRONIC INFLAMMATION | 2018 |
|
RU2785342C2 |
AMIDES OF CONDENSED PIPERIDINE AS MODULATORS OF ION CHANNELS | 2014 |
|
RU2741810C2 |
QUINOLINIL-CONTAINING COMPOUND, ITS PHARMACEUTICAL COMPOSITION AND USE | 2020 |
|
RU2803116C2 |
N-((HET)ARYLMETHYL)-HETEROARYL-CARBOXAMIDE COMPOUNDS AS PLASMA KALLIKREIN INHIBITORS | 2015 |
|
RU2821520C2 |
MDM2 PROTEIN DESTRUCTORS | 2017 |
|
RU2743432C2 |
N-((HET)ARYLMETHYL)-HETEROARYL-CARBOXAMIDE COMPOUNDS AS PLASMA KALLIKREIN INHIBITORS | 2015 |
|
RU2707870C2 |
AROMATIC 6,7-DISUBSTITUTED 3-QUINOLINECARBOXAMIDE DERIVATIVES, METHOD FOR PRODUCTION THEREOF (VARIANTS), PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AND USE THEREOF IN DRUG MANUFACTURING | 2002 |
|
RU2281940C2 |
IMPROVED APELIN RECEPTOR AGONISTS (APJ) AND THEIR USE | 2016 |
|
RU2766148C1 |
Authors
Dates
2016-01-27—Published
2011-08-26—Filed